312
Participants
Start Date
January 31, 2011
Primary Completion Date
January 31, 2016
Study Completion Date
November 30, 2016
GP2013
1000 mg iv infusion on two separate occasions, two weeks apart (i.e. on Day 1 and on Day 15)
MabThera
1000 mg iv infusion on two separate occasions, two weeks apart (i.e. on Day 1 and on Day 15)
Rituxan
1000 mg iv infusion on two separate occasions, two weeks apart (i.e. on Day 1 and on Day 15)
Pest Megyei Flór Ferenc, Kistarcsa
Altoona Center for Clinical Research, Duncansville
Clinical Research Center of Reading LLC, Wyomissing
Klein & Associates, Cumberland
Klein & Associates, Hagerstown
DJL Clinical Research PLLC, Charlotte
Low Country Rheumatology, PA, Charleston
West Tennessee Research Institute, Jackson
Bluegrass Community Research, Inc., Lexington
Physician Research Collaboration, LLC, Lincoln
Health Research of Oklahoma, Oklahoma City
Arthritis & Osteoporosis Center of South Texas, San Antonio
Innovative Health Research, Las Vegas
Miller Clinical Research, Los Angeles
The Seattle Arthritis Center, Seattle
Clinical Pharmacology Study Group, Worcester
Regional Health Clinical Research, Rapid City
Investigative Site, Buenos Aires
Investigative Site, Innsbruck
Investigative Site, Vienna
Investigative site, Kortrijk
Investigative site, Merksem
Investigative Site, Curitiba
Investigative Site, Goiânia
Investigative Site, São Paulo
North Estonia Medical Centre Foundation, Tallinn
Investigative Site, Amiens
Investigative site, Cahors
Investigative Site, Corbeil-Essonnes
Investigative site, La Gaillarde
Investigative Site, Orléans
Investigative Site, Frankfurt
Investigative Site, Freiburg im Breisgau
Investigative Site, Göttingen
Investigative Site, Hildesheim
Investigative Site, Jena
Investigative Site, München
Investigative Site, Nuremberg
Investigative Site, Ratingen
Investigative Site, Regensburg
Investigative Site, Würzburg
Investigative site, Ajmer
Investigative Site, Bangalore
Investigative Site, Hyderabad
Investigative Site, Jaipur
Investigative Site, New Delhi
Investigative Site, Secunderabad
Investigative Site, Milan
Investigative site, Bucharest
Investigative site, Cluj-Napoca
Investigative Site, Madrid
Investigative Site, Mérida
Investigative site, Santiago de Compostela
Investigative Site, Seville
Investigative Site, Istanbul
Investigative Site, Izmir
Megyei Csolnoky Ferenc Kórház Nonprofit Zrt., Veszprém
Lead Sponsor
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
Sandoz
INDUSTRY